RESUMO
BACKGROUND: The Rule of 7's classifies children as low-risk for Lyme meningitis with the absence of the following: ≥7 days of headache, any cranial neuritis or ≥70% cerebrospinal fluid mononuclear cells. We sought to broadly validate this clinical prediction rule in children with meningitis undergoing evaluation for Lyme disease. METHODS: We performed a patient-level data meta-analysis of 2 prospective and 2 retrospective cohorts of children ≤21 years of age with cerebrospinal fluid pleocytosis who underwent evaluation for Lyme disease. We defined a case of Lyme meningitis with a positive 2-tier serology result (positive or equivocal first-tier enzyme immunoassay followed by a positive supplemental immunoblot). We applied the Rule of 7's and report the accuracy for the identification of Lyme meningitis. RESULTS: Of 721 included children with meningitis, 178 had Lyme meningitis (24.7%) and 543 had aseptic meningitis (75.3%). The pooled data from the 4 studies showed the Rule of 7's has a sensitivity of 98% [95% confidence interval (CI): 89%-100%, I2 = 71%], specificity 40% (95% CI: 30%-50%, I2 = 75%), and a negative predictive value of 100% (95% CI: 95%-100%, I2 = 55%). CONCLUSIONS: The Rule of 7's accurately identified children with meningitis at low-risk for Lyme meningitis for whom clinicians should consider outpatient management while awaiting Lyme disease test results.
Assuntos
Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Meningites Bacterianas/diagnóstico , Meningite/diagnóstico , Meningite/microbiologia , Adolescente , Criança , Pré-Escolar , Confiabilidade dos Dados , Diagnóstico Diferencial , Humanos , Técnicas Imunoenzimáticas , Doença de Lyme/líquido cefalorraquidiano , Meningite/líquido cefalorraquidiano , Meningite/classificação , Meningites Bacterianas/líquido cefalorraquidiano , Meningites Bacterianas/microbiologia , Valor Preditivo dos Testes , Estudos Prospectivos , Estudos Retrospectivos , Adulto JovemAssuntos
Dor nas Costas/líquido cefalorraquidiano , Líquido Cefalorraquidiano/citologia , Neuroborreliose de Lyme/diagnóstico , Linfócitos/citologia , Paresia/líquido cefalorraquidiano , Dor nas Costas/diagnóstico , Dor nas Costas/etiologia , Líquido Cefalorraquidiano/química , Líquido Cefalorraquidiano/imunologia , Diagnóstico Diferencial , Ensaio de Imunoadsorção Enzimática , Humanos , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Neuroborreliose de Lyme/líquido cefalorraquidiano , Linfócitos/patologia , Masculino , Pessoa de Meia-Idade , Paresia/diagnóstico , Paresia/etiologia , Plasmócitos/citologia , Plasmócitos/patologiaRESUMO
Background: The Lyme PCR is a direct detection test, but has not been rigorously evaluated in children undergoing evaluation for acute Lyme disease. Methods: We performed a six-center prospective cohort study of children aged 1 to 21 years undergoing acute evaluation for Lyme disease. For this planned secondary analysis, we limited our cohort to children undergoing evaluation for Lyme disease who had any Lyme PCR test obtained by a treating clinician (blood, synovial fluid, or cerebrospinal fluid). We defined a case of Lyme disease with a positive two-tier Lyme disease serology: a positive or equivocal enzyme immunoassay followed by a positive supplemental immunoblot interpreted using standard criteria. We report the test characteristics of Lyme PCR for the diagnosis of Lyme disease. Results: We identified 124 children of whom 54 (43.5%) had Lyme disease. Overall, 23 had a positive PCR test (sensitivity 41.8%; 95% confidence interval [CI] 29.7-55.0; specificity 100%, 95% CI: 94.2-100). All children with a positive Lyme PCR also had a positive two-tiered Lyme disease serology. Conclusions: The Lyme disease PCR test did not improve the diagnosis of children undergoing evaluation for acute Lyme disease. Given the additional costs of this low utility test, clinicians should not order Lyme PCR testing in the acute care setting.
Assuntos
Doença de Lyme/diagnóstico , Reação em Cadeia da Polimerase/métodos , Adolescente , Criança , Estudos de Coortes , Feminino , Humanos , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Masculino , Estudos Prospectivos , Sensibilidade e EspecificidadeRESUMO
In the United States, laboratories frequently offer multiple different assays for testing of cerebrospinal fluid (CSF) samples to provide laboratory support for the diagnosis of central nervous system Lyme disease (CNSLD). Often included among these diagnostic tests are the same enzyme immunoassays and immunoblots that are routinely used to detect the presence of antibodies to Borrelia burgdorferi in serum. However, performing these assays on CSF alone may yield positive results simply from passive diffusion of serum antibodies into the CSF. In addition, such tests are only U.S. Food and Drug Administration cleared and well validated for testing serum, not CSF. When performed using CSF, positive results from these assays do not establish the presence of intrathecal antibody production to B. burgdorferi and therefore should not be offered. The preferred test to detect intrathecal production of antibodies to B. burgdorferi is the antibody index assay, which corrects for passive diffusion of serum antibodies into CSF and requires testing of paired serum and CSF collected at approximately the same time. However, this assay also has limitations and should only be used to establish a diagnosis of CNSLD in conjunction with patient exposure history, clinical presentation, and other laboratory findings.
Assuntos
Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/líquido cefalorraquidiano , Testes Diagnósticos de Rotina/normas , Neuroborreliose de Lyme/diagnóstico , Borrelia burgdorferi/imunologia , Diagnóstico Diferencial , Humanos , Técnicas Imunoenzimáticas , Imunoglobulina G/sangue , Imunoglobulina G/líquido cefalorraquidiano , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/diagnóstico , Neuroborreliose de Lyme/sangue , Neuroborreliose de Lyme/líquido cefalorraquidiano , Estados UnidosRESUMO
Early neurological Lyme disease (neuroborreliosis) typically presents with well-recognised neurological syndromes. Spinal myoclonus is however a rare manifestation of neuroborreliosis. We present the case of a man who developed spinal myoclonus 3 weeks after returning from the Czech Republic where he developed erythema migrans on his arm following multiple tick exposures. Spinal fluid analysis showed a pleocytosis and MRI showed enhancement at C5-C6. His serology was positive for IgM antibodies to Borrelia afzelli He was successfully treated with ceftriaxone and doxycycline with improvement of his spinal myoclonus and radiculitis. We conclude that early Lyme neuroborreliosis may present with uncommon neurological manifestations and so a high degree of suspicion is needed.
Assuntos
Doença de Lyme/diagnóstico , Neuroborreliose de Lyme/complicações , Mioclonia/etiologia , Administração Intravenosa , Idoso , Antibacterianos/administração & dosagem , Antibacterianos/uso terapêutico , Ceftriaxona/administração & dosagem , Ceftriaxona/uso terapêutico , Diagnóstico Diferencial , Humanos , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/tratamento farmacológico , Doença de Lyme/microbiologia , Imageamento por Ressonância Magnética/métodos , Masculino , Doenças da Medula Espinal/diagnóstico por imagem , Doenças da Medula Espinal/tratamento farmacológico , Doenças da Medula Espinal/microbiologia , Doenças da Medula Espinal/fisiopatologia , Punção Espinal/métodos , Picadas de Carrapatos/complicações , Picadas de Carrapatos/microbiologia , Resultado do TratamentoRESUMO
We identified 620 children with peripheral facial palsy of which 211 (34%) had Lyme disease. The 140 children who had a lumbar puncture performed were more likely to be hospitalized (73% LP performed vs 2% no LP) and to receive parenteral antibiotics (62% LP performed vs 6% no LP).
Assuntos
Paralisia Facial/diagnóstico , Doença de Lyme/diagnóstico , Punção Espinal , Adolescente , Boston , Criança , Estudos Transversais , Paralisia Facial/líquido cefalorraquidiano , Paralisia Facial/etiologia , Feminino , Humanos , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/complicações , Masculino , Estudos RetrospectivosRESUMO
Lyme disease (LD) is a tick-borne infection that is endemic to multiple areas of the United States. Patients with LD may present with sign and symptoms of intracranial hypertension (IH). The objective of this study is to evaluate the history, clinical findings, CSF analysis, and brain imaging results in pediatric patients with increased intracranial pressure secondary to LD. A retrospective database search was performed using the International Classification of Diseases (ICD) 9/10 codes to identify patients diagnosed with LD and IH between 2004 and 2014 at a tertiary referral pediatric hospital. Clinical, laboratory and neuroimaging data for each patient were reviewed. Seven patients met inclusion criteria; mean age was 9.6 years (standard deviation 4.0 years); 4/7 patients were male. Average body mass index was 18.8 kg/m(2) (standard deviation 3.0 kg/m(2)). Fever was present in four patients. Four had a history of LD related erythema migrans. All had elevated CSF opening pressure with leukocytosis and lymphocytic predominance. MRI obtained in six patients showed contrast enhancement of various cranial nerves. Tentorial enhancement was noted in all patients. In addition, patients had widening of the optic nerve sheath (ONS), optic nerve protrusion, and flattening of the posterior globe consistent with increased intracranial pressure. All patients had resolution of their symptoms after initiation of antibiotic therapy. In endemic areas, LD should be included in the differential of IH. MRI can help distinguish IH due to LD from its idiopathic form due to the presence of tentorial and cranial nerve enhancement in the former in addition to abnormal CSF showing leukocytosis with lymphocyte predominance.
Assuntos
Hipertensão Intracraniana/complicações , Hipertensão Intracraniana/diagnóstico por imagem , Doença de Lyme/complicações , Doença de Lyme/diagnóstico por imagem , Imageamento por Ressonância Magnética , Adolescente , Antibacterianos/uso terapêutico , Ceftriaxona/uso terapêutico , Criança , Pré-Escolar , Estudos de Coortes , Doxiciclina/uso terapêutico , Feminino , Humanos , Processamento de Imagem Assistida por Computador , Hipertensão Intracraniana/líquido cefalorraquidiano , Doença de Lyme/líquido cefalorraquidiano , Masculino , Nervo Óptico/diagnóstico por imagem , Índice de Gravidade de DoençaRESUMO
The varying clinical manifestations of Lyme borreliosis, transmitted by Ixodes ricinus and caused by Borrelia burgdorferi, frequently pose diagnostic problems. Diagnostic strategies vary between early and late disease manifestations and usually include serological methods. Erythema migrans is pathognomonic and does not require any further laboratory investigations. In contrast, the diagnosis of neuroborreliosis requires the assessment of serum and cerebrospinal fluid. Lyme arthritis is diagnosed in the presence of newly recognized arthritis and high-titer serum IgG antibodies against B. burgdorferi. The committee concludes the following recommendations: Borrelial serology should only be ordered in case of well-founded clinical suspicion for Lyme borreliosis, i.e., manifestations compatible with the diagnosis. Tests for borrelial genomic sequences in ticks or lymphocyte proliferation assays should not be ordered. When results of such tests or of serological investigations that were not indicated are available, they should not influence therapeutic decisions. Laboratories should be cautious when interpreting results of serological tests and abstain from giving therapeutic recommendations and from proposing retesting after some time without intimate knowledge of patient's history and disease manifestations.
Assuntos
Borrelia burgdorferi/isolamento & purificação , Doença de Lyme/diagnóstico , Adolescente , Animais , Antígenos de Bactérias/imunologia , Artrite Infecciosa/diagnóstico , Borrelia burgdorferi/imunologia , Criança , Eritema Migrans Crônico/diagnóstico , Humanos , Ixodes/microbiologia , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Neuroborreliose de Lyme/diagnósticoRESUMO
The serological diagnosis of Lyme borreliosis is accomplished by the detection of IgG and IgM antibodies specific for relevant antigens of the spirochetal pathogen Borrelia burgdorferi. Instead of the usual enzyme immune assay for screening and the Western blot technique for confirmation, bead based multiplex assays with multiple simultaneously performed distinct reactions can provide quick, automatically derived and reliable results in a single run by flow cytometer technology. The broad analytical dynamic range of assay signals and the high sensitivity and specificity of the multiplex formats allow even for a reliable use in CSF based analyses for antibody specificity index in supposed neuroborreliosis. Fluorescence intensity of the bead based reactions can be transformed into quantified values as U/ml, either for each single antigen or summed up for a group of relevant key antigens. Additionally or alternatively distinct reactions of single bead populations can be transformed to Western blot band equivalents. Internal and external quality controls with the multiplex systems show characteristic data equivalent to the conventional assay formats, so that the advantages of the multiplex assays are ready for use in the routine diagnostic laboratory.
Assuntos
Anticorpos Antibacterianos/sangue , Borrelia burgdorferi/imunologia , Doença de Lyme/diagnóstico , Algoritmos , Animais , Anticorpos Antibacterianos/líquido cefalorraquidiano , Antígenos de Bactérias/imunologia , Interpretação Estatística de Dados , Humanos , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/imunologia , Microesferas , Controle de Qualidade , Kit de Reagentes para Diagnóstico , Padrões de Referência , Sensibilidade e Especificidade , Testes Sorológicos/métodos , Testes Sorológicos/normasRESUMO
This study determined the prevalence of Lyme meningitis in children with undifferentiated aseptic meningitis from April to December in a Lyme disease-endemic region. Of the 60 children, 8 were seropositive (prevalence 13.3%; 95% confidence interval: 6.3-25.1%), with another probable case having high cerebrospinal fluid antibody titers. Clinicians in endemic regions should evaluate children with undifferentiated aseptic meningitis for Lyme meningitis in appropriate seasons.
Assuntos
Borrelia burgdorferi/isolamento & purificação , Doenças Endêmicas/prevenção & controle , Leucocitose/líquido cefalorraquidiano , Doença de Lyme/diagnóstico , Meningite Asséptica/diagnóstico , Adolescente , Borrelia burgdorferi/fisiologia , Criança , Pré-Escolar , Diagnóstico Diferencial , Ensaio de Imunoadsorção Enzimática , Feminino , Humanos , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/epidemiologia , Masculino , Meningite Asséptica/sangue , Meningite Asséptica/líquido cefalorraquidiano , Meningite Asséptica/epidemiologia , Prevalência , Estudos Prospectivos , Rhode Island , Estações do AnoRESUMO
Plant and animal biodiversity are essential to ecosystem health and can provide benefits to humans ranging from aesthetics to maintaining air quality. Although the importance of biodiversity to ecology and conservation biology is obvious, such measures have not been applied to strains of an invasive bacterium found in human tissues during infection. In this study, we compared the strain biodiversity of Borrelia burgdorferi found in tick populations with that found in skin, blood, synovial fluid or cerebrospinal fluid of Lyme disease patients. The biodiversity of B. burgdorferi strains is significantly greater in tick populations than in the skin of patients with erythema migrans. In turn, strains from skin are significantly more diverse than strains at any of the disseminated sites. The cerebrospinal fluid of patients with neurologic Lyme disease harbored the least pathogen biodiversity. These results suggest that human tissues act as niches that can allow entry to or maintain only a subset of the total pathogen population. These data help to explain prior clinical observations on the natural history of B. burgdorferi infection and raise several questions that may help to direct future research to better understand the pathogenesis of this infection.
Assuntos
Borrelia burgdorferi/classificação , Doença de Lyme/microbiologia , Animais , Biodiversidade , Ecossistema , Humanos , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Pele/microbiologia , Líquido Sinovial/microbiologia , Carrapatos/microbiologiaRESUMO
BACKGROUND: Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS) are syndromes of unknown etiology. They share features of fatigue and cognitive dysfunction, making it difficult to differentiate them. Unresolved is whether nPTLS is a subset of CFS. METHODS AND PRINCIPAL FINDINGS: Pooled cerebrospinal fluid (CSF) samples from nPTLS patients, CFS patients, and healthy volunteers were comprehensively analyzed using high-resolution mass spectrometry (MS), coupled with immunoaffinity depletion methods to reduce protein-masking by abundant proteins. Individual patient and healthy control CSF samples were analyzed directly employing a MS-based label-free quantitative proteomics approach. We found that both groups, and individuals within the groups, could be distinguished from each other and normals based on their specific CSF proteins (p<0.01). CFS (nâ=â43) had 2,783 non-redundant proteins, nPTLS (nâ=â25) contained 2,768 proteins, and healthy normals had 2,630 proteins. Preliminary pathway analysis demonstrated that the data could be useful for hypothesis generation on the pathogenetic mechanisms underlying these two related syndromes. CONCLUSIONS: nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions.
Assuntos
Proteínas do Líquido Cefalorraquidiano/análise , Síndrome de Fadiga Crônica/líquido cefalorraquidiano , Síndrome de Fadiga Crônica/diagnóstico , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/diagnóstico , Proteoma/análise , Adolescente , Adulto , Estudos de Casos e Controles , Proteínas do Líquido Cefalorraquidiano/metabolismo , Diagnóstico Diferencial , Síndrome de Fadiga Crônica/metabolismo , Síndrome de Fadiga Crônica/terapia , Feminino , Humanos , Doença de Lyme/metabolismo , Doença de Lyme/terapia , Masculino , Pessoa de Meia-Idade , Proteômica/métodos , Resultado do Tratamento , Adulto JovemRESUMO
BACKGROUND: Lyme disease is an animal-borne disease, caused by spirochetes of the Borrelia burgdorferi (Bb). The infection is transmitted by ticks of the Ixodes ricinus species. Humans are infected through a tick bite to the skin. The aim of the study was evaluation of epidemiology, symptoms and serologic factors in Lyme disease. MATERIAL AND METHODS: We have enrolled 39 patients from Malopolska region in the study treated for Lyme borreliosis. History of tick biting, clinical signs and symptoms and serological tests were evaluated. RESULTS: The most common symptoms were headaches and pain of the large joints. Patients with untreated erithema migrans (EM) more often developed symptoms from nervous system (83%) than joints (54%). We found abnormalities which confirmed inflammation in CSF in 24.3% of patients. Patients with positive IgG antibodies against Bb in CSF and confirmed their intrathecal synthesis had never had EM in the past. CONCLUSIONS: There is low percentage of the patients who were treated due to EM. Patients with untreated EM more often developed symptoms from nervous system than joints. The most common symptoms among our patients were headaches and pain of large joints.
Assuntos
Doença de Lyme/diagnóstico , Doença de Lyme/epidemiologia , Adulto , Artralgia/etiologia , Feminino , Cefaleia/etiologia , Humanos , Imunoglobulina G/análise , Incidência , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/complicações , Masculino , Anamnese , Pessoa de Meia-Idade , Polônia/epidemiologia , Testes SorológicosRESUMO
The dynamics of Borrelia burgdorferi infections within its natural hosts are poorly understood. We necropsied four wild-caught western gray squirrels (Sciurus griseus) that were acquired during a previous study that evaluated the reservoir competence of this rodent for the Lyme disease spirochete. One animal was infected experimentally, whereas the others were infected in the wild before capture. To investigate dissemination of B. burgdorferi and concurrent histopathologic lesions in different tissues, blood specimens, synovial and cerebrospinal fluid, ear-punch biopsies, and diverse tissue samples from skin and various organs were taken and examined by culture, polymerase chain reaction, and histology. Borrelia-positive cultures were obtained from three of the squirrels, that is, from skin biopsies (7 of 20 samples), ear-punch biopsies (2 of 8), and one (1 of 5) lymph node. Sequencing of amplicons confirmed B. burgdorferi sensu stricto (s.s.) infection in 9 of 10 culture-positive samples and in DNA extracted from all 10 positive cultures. The experimentally infected squirrel yielded most of the positive samples. In contrast, bodily fluids, all other organ specimens from these animals, and all samples from one naturally infected squirrel were negative for Borrelia for both assays. None of the necropsied squirrels exhibited specific clinical signs associated with B. burgdorferi. Similarly, necropsy and histological examination of tissues indicated the presence of underlying infectious processes, none of which could be ascribed conclusively to B. burgdorferi infection. Based on these results, obtained from a small number of animals investigated at a single time point, we suggest that B. burgdorferi s.s. infection in S. griseus may result in rather localized dissemination of spirochetes, and that mild or nonclinical disease might be more common after several months of infection duration. Since spirochetes could be detected in squirrels 7-21 months postinfection, we conclude that S. griseus can infect Ixodes pacificus ticks with B. burgdorferi s.s. trans-seasonally.
Assuntos
Borrelia burgdorferi/isolamento & purificação , Doença de Lyme/veterinária , Sciuridae , Animais , Reservatórios de Doenças/microbiologia , Reservatórios de Doenças/veterinária , Orelha/microbiologia , Doença de Lyme/sangue , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/microbiologia , Linfonodos/microbiologia , Pele/microbiologia , Líquido Sinovial/microbiologiaRESUMO
The frequency of taste disorders in idiopathic facial palsy (IFP) and B. burgdorferi-associated facial palsy (BFP) was retrospectively assessed in a cohort of patients with acute peripheral facial palsy (AFP). A significant (>10/microl) CSF pleocytosis was found in 17% of the patients who underwent lumbar puncture for AFP. In two centres, 26 patients with BFP were identified by CSF and serological criteria. The control group (patients with IFP) consisted of 59 patients from one of the centres in whom BFP was excluded by CSF examination. AFP patients of both centres are routinely questioned about taste disorders according to the hospitals' standards. A taste disorder was found in 46% of the IFP and 31% of the BFP cases (not significant). About one-third of the BFP patients complained of radicular or back pain. We conclude that a history of taste disorder is not helpful in distinguishing clinically between BFP and IFP.
Assuntos
Borrelia burgdorferi , Paralisia Facial/etiologia , Doença de Lyme/complicações , Doença de Lyme/diagnóstico , Distúrbios do Paladar/epidemiologia , Anticorpos Antibacterianos , Dor nas Costas/diagnóstico , Estudos de Coortes , Diagnóstico Diferencial , Paralisia Facial/líquido cefalorraquidiano , Paralisia Facial/diagnóstico , Cefaleia/diagnóstico , Humanos , Leucocitose/líquido cefalorraquidiano , Leucocitose/diagnóstico , Leucocitose/epidemiologia , Doença de Lyme/líquido cefalorraquidiano , Pessoa de Meia-Idade , Dor/diagnóstico , Prevalência , Estudos Retrospectivos , Punção Espinal , Distúrbios do Paladar/líquido cefalorraquidiano , Distúrbios do Paladar/diagnósticoRESUMO
INTRODUCTION: Lyme disease is a multi-organ animal-borne disease caused by the spirochete Borrelia burgdorferi (Bb). OBJECTIVES: As the pathogenesis of Lyme borreliosis is not fully understood, the study has been designed to examine levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) and soluble intercellular adhesion molecule-1 (sICAM-1) in serum and the cerebrospinal fluid (CSF) of patients with Lyme borreliosis and their associations with clinical signs and symptoms and anti-Borrelia burgdorferi (anti-Bb) antibody titers. PATIENTS AND METHODS: Sixty-four patients were enrolled in the study, including 39 patients treated for Lyme borreliosis and 25 without the disease (control group). In both groups sVCAM-1 and sICAM-1 levels were determined in serum and the CSF. RESULTS: Mean serum sICAM-1 and sVCAM-1 levels were higher in patients with Lyme borreliosis than in the control group. Serum sICAM-1 levels were significantly lower among patients with results positive for immunoglobulin M seroreactivity with Bb than among those with negative antibody responses. In patients with Bb-specific serum immunoglobulin G (IgG) antibodies, significantly higher serum sICAM-1 levels were found. Higher sVCAM-1 and sICAM-1 levels in the CSF were observed in patients positive for anti-Bb IgG antibody titers in the CSF. CONCLUSIONS: In patients with Lyme borreliosis, endothelial cell activation results in elevated levels of sICAM-1 and sVCAM-1 in serum and the CSF.
Assuntos
Molécula 1 de Adesão Intercelular/sangue , Doença de Lyme/sangue , Doença de Lyme/diagnóstico , Molécula 1 de Adesão de Célula Vascular/sangue , Adulto , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Borrelia burgdorferi/imunologia , Líquido Cefalorraquidiano/imunologia , Feminino , Humanos , Imunoglobulina G/metabolismo , Doença de Lyme/líquido cefalorraquidiano , Masculino , Pessoa de Meia-Idade , Testes SorológicosRESUMO
BACKGROUND: The tick-borne bacteria Borrelia burgdorferi sensu lato (sl) and Anaplasma phagocytophilum have been suspected to cause neurological signs in dogs. Diagnosis often has been made based on positive antibody titers in serum of dogs with neurological signs, but a high seroprevalence in dogs in at-risk populations makes diagnosis difficult. OBJECTIVE: To determine if the neurological signs in dogs examined were caused by any of these bacteria. ANIMALS: Fifty-four dogs presented to a board-certified neurologist. METHODS: Prospective study. We divided dogs into 2 groups: those with inflammatory diseases of the central nervous system (CNS) and those with neurological signs from other diseases. Blood and cerebrospinal fluid (CSF) from all dogs were analyzed. RESULTS: Dogs with inflammatory CNS diseases showed no serum antibodies against any of the agents. Among dogs with neurological signs from other diseases, 10.3% had serum antibodies for B. burgdorferi sl and 20.5% for A. phagocytophilum. All blood samples analyzed for bacterial deoxyribonucleic acid (DNA) and all CSF analyzed for antibodies and bacterial DNA for the 2 agents were negative. CONCLUSIONS AND CLINICAL IMPORTANCE: Based on this study, these bacteria are unlikely causes of neurologic disease in dogs and the presence of serum antibodies alone does not document or establish a definitive diagnosis of CNS disease caused by these organisms. Dogs that have neurologic disease and corresponding serum antibodies against these agents should have additional tests performed to assess for other potential etiologies of the signs.
Assuntos
Anaplasmose/diagnóstico , Anticorpos Antibacterianos/líquido cefalorraquidiano , Doenças do Sistema Nervoso Central/veterinária , Doenças do Cão/diagnóstico , Doença de Lyme/veterinária , Reação em Cadeia da Polimerase/veterinária , Anaplasmose/líquido cefalorraquidiano , Animais , Grupo Borrelia Burgdorferi , Doenças do Sistema Nervoso Central/líquido cefalorraquidiano , Doenças do Sistema Nervoso Central/diagnóstico , Doenças do Sistema Nervoso Central/microbiologia , Doenças do Cão/microbiologia , Cães , Feminino , Doença de Lyme/líquido cefalorraquidiano , Doença de Lyme/imunologia , MasculinoRESUMO
BACKGROUND: A prediction model based on clinical and cerebrospinal fluid (CSF) analysis has been proposed for the differentiation of Lyme meningitis (LM) from non-Lyme aseptic meningitis (NLAM) in the United States. No similar model has ever been proposed for European patients. The objective of our study was to develop a prediction model to differentiate LM from NLAM based on clinical and CSF biologic data. METHODS: The medical charts of all children older than 2 years of age admitted to our hospital from 1996 through 2006 with a definite diagnosis of LM were analyzed and compared retrospectively with those having a diagnosis of NLAM. Chart review included the duration of symptoms, the presence of cranial neuropathy, and CSF analysis. RESULTS: A total of 93 patients were included (LM: 26 patients; NLAM: 67 patients) in the study. Patients with LM had statistically more frequent cranial neuropathy (73% vs. 4%), displayed a longer duration of symptoms before admission (8.8 vs. 1.8 days), had a higher CSF protein (71 vs. 38 mg/d), and had a lower percentage of neutrophil cells in the CSF (3.4% vs. 51%) than patients with NLAM. A predicted probability was derived from these 4 variables. At a cutoff point of >0.432, the model had a negative predictive value of 100% and a positive predictive value of 92.3%, with a sensitivity of 100% and a specificity of 97%. CONCLUSIONS: We report the first European prediction model for LM. Owing to its high negative predictive value, this model may assist physicians in managing aseptic meningitis (AM) while awaiting serologic tests, especially in Lyme endemic regions.